Brent H. Cochran

Title: Professor
Company: Tufts University School of Medicine
Location: Newton, Massachusetts

Brent Cochran, Professor at the Tufts University School of Medicine, has been recognized by Marquis Who’s Who Top Educators for dedication, achievements, and leadership as an endocrinology and molecular genetics educator.

Dr. Cochran studied at the Massachusetts Institute of Technology (MIT), where he earned a Bachelor of Science in 1978. He continued his education at Harvard University, earned a PhD in 1984, and in 1985, he returned to his alma mater, MIT, as an assistant professor of biology. In 1993, he transitioned to a position as an associate professor of physiology at the Tufts University School of Medicine. Dr. Cochran worked in this position for nine years, and in 2002, he rose to the rank of full professor at the university, where he continues to teach endocrinology and molecular genetics to this day. He credits his professor Jerry Lettvin and his thesis advisor Chuck Stiles as mentors in his career, and he cites Noam Chomsky and Nobel Laureate Philip Sharp as major influences.

In addition to his work as a medical educator, Dr. Cochran has conducted research on cell growth regulation, cancer, and stem cells. He has maintained memberships to multiple professional organizations, including the American Association for the Advancement of Science, the Society for Neuro-Oncology, the American Association for Cancer Research, and the International Society for Stem Cell Research. Dr. Cochran is proudest of his work in discovering the first growth factor regulated genes and proto-oncogenes, as well as discovering the sis/PDGF (Platelet-Derived Growth Factor) inducible factor, which was originally termed SIF (Sis-Inducible Factor) but was later renamed to STATs (Signal Transducers and Activators of Transcription). In the coming years, Dr. Cochran is working on building computational models for brain tumor stem cells, with the goal of being able to create personalized predictions for which drugs would be best for tumor treatment based on the patient’s genetics.

For more information, please visit:

Cochran Lab

Contact Dr. Cochran:

Leave a Reply